Which of the following drugs has been found to increase the survival in locally advanced pancreatic cancer?: (A) Doxorubicin, (B) Streptozocin, (C) Gemcitabine, (D) Paclitaxel
Answer is C. Gemcitabine is currently the standard of care for patients with metastatic pancreatic cancer.